Global Biopreservation Market Size Study & Forecast, by Product (Equipment, Media, LIMS) by Application (Regenerative Medicine, Bio-banking, Drug Discovery) and Regional Forecasts 2025-2035

The Global Biopreservation Market is valued at approximately USD 3.59 billion in 2024 and is anticipated to expand at a remarkable CAGR of 28.30% over the forecast period 2025-2035. Biopreservation, at its core, refers to the process of maintaining the integrity and functionality of biological samples-such as cells, tissues, and organs-by leveraging specialized preservation techniques and solutions. This market has gained tremendous traction as the lifesciences ecosystem accelerates innovation, with research institutes, pharmaceutical giants, and biotechnology firms increasingly depending on preserved biospecimens for clinical trials, advanced therapeutics, and translational research. The surge in demand for personalized medicine, stem cell therapies, and regenerative treatments is fueling the adoption of biopreservation technologies, while increasing investment in advanced storage equipment and cryoprotective media further strengthens the market outlook.

The rising need for robust bio-banking solutions and the ongoing expansion of regenerative medicine research are catalyzing the global demand for biopreservation products. With an unprecedented volume of biological material being stored and utilized for drug discovery pipelines and personalized healthcare programs, laboratories and healthcare providers are racing to adopt reliable preservation methods that ensure sample viability over extended timeframes. For instance, the rising volume of stem cell transplants worldwide underscores the indispensability of biopreservation in modern medicine. In addition, the advent of AI-integrated Laboratory Information Management Systems (LIMS) and automation-driven cryogenic technologies is opening lucrative opportunities for the market, while the growing inclination toward decentralized clinical trials enhances the need for effective specimen management. However, the substantial costs of preservation equipment and stringent regulatory frameworks governing biospecimen handling may challenge the market's growth trajectory during 2025-2035.

The detailed segments and sub-segments included in the report are:

By Product:

• Equipment
• Media
• LIMS

By Application:

• Regenerative Medicine
• Bio-banking
• Drug Discovery

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
• Regenerative medicine is projected to dominate the market, accounting for the largest share during the forecast period. The sector's growth stems from the rising number of clinical trials focusing on stem cell and gene therapies, coupled with surging investments from both government and private entities to advance tissue engineering and cell therapy solutions. The strong emphasis on next-generation therapeutics for chronic illnesses and rare diseases has firmly positioned regenerative medicine at the forefront of biopreservation adoption. While bio-banking is also gaining significance due to the establishment of national and private biorepositories, regenerative medicine continues to lead as the primary revenue driver because of its transformative role in redefining healthcare solutions.
• In terms of product categories, equipment currently holds the largest revenue share within the biopreservation market. Cryogenic freezers, liquid nitrogen systems, and advanced storage infrastructure remain essential for ensuring sample viability and scalability across large repositories. The demand for automated storage equipment has surged as healthcare institutions and research laboratories grapple with the complexities of storing vast biological datasets. Nevertheless, biopreservation media-designed to enhance sample stability and reduce cryoinjury-is expected to expand at the fastest CAGR over the forecast horizon, propelled by innovation in cryoprotective agents and customized formulations tailored to cell-specific requirements. Hence, while equipment dominates today in terms of sheer revenue, media emerges as the growth engine for the next decade.
• The Global Biopreservation Market demonstrates varied growth dynamics across regions. North America has traditionally led the sector, driven by its strong research infrastructure, advanced healthcare system, and high adoption of regenerative medicine technologies. The region's growing stem cell banking initiatives, combined with increased funding in precision medicine, cement its leadership position. Meanwhile, the Asia Pacific region is poised to experience the fastest growth, bolstered by rapid industrialization, expanding biotech clusters, and government-supported initiatives in China, India, and Japan to strengthen biobanking and clinical research. Europe continues to hold a significant market share due to the presence of robust pharmaceutical and biotechnology industries, whereas Latin America and the Middle East & Africa are gradually emerging as promising regions, supported by rising healthcare expenditure and growing interest in advanced therapeutic research.

Major market players included in this report are:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Becton, Dickinson and Company
• BioLife Solutions Inc.
• PHC Holdings Corporation
• Lonza Group AG
• Chart Industries, Inc.
• Avantor, Inc.
• Corning Incorporated
• Cryoport, Inc.
• Brooks Life Sciences (Azenta Life Sciences)
• Precision BioLogic Inc.
• Stemcell Technologies Inc.
• VWR International, LLC (Avantor)
• LabVantage Solutions, Inc.

Global Biopreservation Market Report Scope:

• Historical Data - 2023, 2024
• Base Year for Estimation - 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.